Your browser doesn't support javascript.
loading
Mediation of Successful Reperfusion Effect through Infarct Growth and Cerebral Edema: A Pooled, Patient-Level Analysis of EXTEND-IA Trials and SELECT Prospective Cohort.
Sarraj, Amrou; Pujara, Deep K; Churilov, Leonid; Sitton, Clark W; Ng, Felix; Hassan, Ameer E; Abraham, Michael G; Blackburn, Spiros L; Sharma, Gagan; Yassi, Nawaf; Kleinig, Timothy; Shah, Darshan; Wu, Teddy Y; Tekle, Wondwossen G; Budzik, Ronald F; Hicks, William J; Vora, Nirav; Edgell, Randall C; Haussen, Diogo; Ortega-Gutierrez, Santiago; Toth, Gabor; Maali, Laith; Abdulrazzak, Mohammad Ammar; Al-Shaibi, Faisal; AlMaghrabi, Tareq; Yogendrakumar, Vignan; Shaker, Faris; Mir, Osman; Arora, Ashish; Duncan, Kelsey; Sundararajan, Sophia; Opaskar, Amanda; Hu, Yin; Ray, Abhishek; Sunshine, Jeffrey; Bambakidis, Nicholas; Martin-Schild, Sheryl; Hussain, M Shazam; Nogueira, Raul; Furlan, Anthony; Sila, Cathy A; Grotta, James C; Parsons, Mark; Mitchell, Peter J; Donnan, Geoffrey A; Davis, Stephen M; Albers, Gregory W; Campbell, Bruce C V.
Afiliación
  • Sarraj A; Department of Neurology, Case Western Reserve University, Cleveland, OH, USA.
  • Pujara DK; Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
  • Churilov L; Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
  • Sitton CW; Department of Neurology, Royal Melbourne Hospitals, University of Melbourne, Parkville, Victoria, Australia.
  • Ng F; Department of Diagnostic and Interventional Radiology, UTHealth McGovern Medical School, Houston, TX, USA.
  • Hassan AE; Department of Neurology, Royal Melbourne Hospitals, University of Melbourne, Parkville, Victoria, Australia.
  • Abraham MG; University of Texas Rio Grande Valley-Valley Baptist Medical Center, Harlingen, TX, USA.
  • Blackburn SL; Department of Neurology and Radiology, University of Kansas Medical Center, Kansas City, KS, USA.
  • Sharma G; Department of Neurosurgery, UTHealth McGovern Medical School, Houston, TX, USA.
  • Yassi N; Department of Neurology, Royal Melbourne Hospitals, University of Melbourne, Parkville, Victoria, Australia.
  • Kleinig T; Department of Neurology, Royal Melbourne Hospitals, University of Melbourne, Parkville, Victoria, Australia.
  • Shah D; Walter and Eliza Hall Institute of Medical Research, Population Health and Immunity, Parkville, Victoria, Australia.
  • Wu TY; Department of Neurology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
  • Tekle WG; Department of Neurology, Gold Coast University Hospital, Southport, Queensland, Australia.
  • Budzik RF; Department of Neurology, Christchurch Hospital, Christchurch, New Zealand.
  • Hicks WJ; University of Texas Rio Grande Valley-Valley Baptist Medical Center, Harlingen, TX, USA.
  • Vora N; Riverside Methodist Hospital, Colombia, OH, USA.
  • Edgell RC; Riverside Methodist Hospital, Colombia, OH, USA.
  • Haussen D; Riverside Methodist Hospital, Colombia, OH, USA.
  • Ortega-Gutierrez S; Department of Neurology, Saint Louis University, Saint Louis, MO, USA.
  • Toth G; Department of Neurology, Emory University, Atlanta, GA, USA.
  • Maali L; Department of Neurology, University of Iowa, Iowa City, IA, USA.
  • Abdulrazzak MA; Department of Neurology, Cleveland Clinic, Cleveland, OH, USA.
  • Al-Shaibi F; Department of Neurology and Radiology, University of Kansas Medical Center, Kansas City, KS, USA.
  • AlMaghrabi T; Department of Neurology, Cleveland Clinic, Cleveland, OH, USA.
  • Yogendrakumar V; Department of Neurology, Case Western Reserve University, Cleveland, OH, USA.
  • Shaker F; Department of Neurology, University of Tabuk, Tabuk, Kingdom of Saudi Arabia.
  • Mir O; Department of Neurology, Royal Melbourne Hospitals, University of Melbourne, Parkville, Victoria, Australia.
  • Arora A; Department of Neurosurgery, UTHealth McGovern Medical School, Houston, TX, USA.
  • Duncan K; Department of Neurology, Baylor Scott & White Health, Dallas, TX, USA.
  • Sundararajan S; Department of Neurology, Greensboro | Cone Health, Greensboro, NC, USA.
  • Opaskar A; Department of Neurosurgery, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
  • Hu Y; Department of Neurology, Case Western Reserve University, Cleveland, OH, USA.
  • Ray A; Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
  • Sunshine J; Department of Neurosurgery, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
  • Bambakidis N; Department of Neurosurgery, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
  • Martin-Schild S; Department of Neurosurgery, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
  • Hussain MS; Department of Neurosurgery, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
  • Nogueira R; Department of Neurosurgery, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
  • Furlan A; Department of Neurology, Touro Infirmary and New Orleans East Hospital, New Orleans, LA, USA.
  • Sila CA; Department of Neurology, Cleveland Clinic, Cleveland, OH, USA.
  • Grotta JC; Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Parsons M; Department of Neurology, Case Western Reserve University, Cleveland, OH, USA.
  • Mitchell PJ; Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
  • Donnan GA; Department of Neurology, Case Western Reserve University, Cleveland, OH, USA.
  • Davis SM; Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
  • Albers GW; Department of Neurology, Memorial Hermann Hospital Texas Medical Center, Houston, TX, USA.
  • Campbell BCV; Department of Neurology, University of Newcastle, Newcastle, New South Wales, Australia.
Ann Neurol ; 93(4): 793-804, 2023 04.
Article en En | MEDLINE | ID: mdl-36571388
ABSTRACT

OBJECTIVE:

Reperfusion therapy is highly beneficial for ischemic stroke. Reduction in both infarct growth and edema are plausible mediators of clinical benefit with reperfusion. We aimed to quantify these mediators and their interrelationship.

METHODS:

In a pooled, patient-level analysis of the EXTEND-IA trials and SELECT study, we used a mediation analysis framework to quantify infarct growth and cerebral edema (midline shift) mediation effect on successful reperfusion (modified Treatment in Cerebral Ischemia ≥ 2b) association with functional outcome (modified Rankin Scale distribution). Furthermore, we evaluated an additional pathway to the original hypothesis, where infarct growth mediated successful reperfusion effect on midline shift.

RESULTS:

A total 542 of 665 (81.5%) eligible patients achieved successful reperfusion. Baseline clinical and imaging characteristics were largely similar between those achieving successful versus unsuccessful reperfusion. Median infarct growth was 12.3ml (interquartile range [IQR] = 1.8-48.4), and median midline shift was 0mm (IQR = 0-2.2). Of 249 (37%) demonstrating a midline shift of ≥1mm, median shift was 2.75mm (IQR = 1.89-4.21). Successful reperfusion was associated with reductions in both predefined mediators, infarct growth (ß = -1.19, 95% confidence interval [CI] = -1.51 to -0.88, p < 0.001) and midline shift (adjusted odds ratio = 0.36, 95% CI = 0.23-0.57, p < 0.001). Successful reperfusion association with improved functional outcome (adjusted common odds ratio [acOR] = 2.68, 95% CI = 1.86-3.88, p < 0.001) became insignificant (acOR = 1.39, 95% CI = 0.95-2.04, p = 0.094) when infarct growth and midline shift were added to the regression model. Infarct growth and midline shift explained 45% and 34% of successful reperfusion effect, respectively. Analysis considering an alternative hypothesis demonstrated consistent results.

INTERPRETATION:

In this mediation analysis from a pooled, patient-level cohort, a significant proportion (~80%) of successful reperfusion effect on functional outcome was mediated through reduction in infarct growth and cerebral edema. Further studies are required to confirm our findings, detect additional mediators to explain successful reperfusion residual effect, and identify novel therapeutic targets to further enhance reperfusion benefits. ANN NEUROL 2023;93793-804.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Edema Encefálico / Isquemia Encefálica / Accidente Cerebrovascular / Procedimientos Endovasculares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Neurol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Edema Encefálico / Isquemia Encefálica / Accidente Cerebrovascular / Procedimientos Endovasculares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Neurol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos